| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.005 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | -0.095 | 0.006 |
| mRNA | BRD-K17060750 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.007 |
| mRNA | Vinblastine | GDSC1000 | pan-cancer | AAC | -0.091 | 0.007 |
| mRNA | QL-VIII-58 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.007 |
| mRNA | lapatinib | GDSC1000 | pan-cancer | AAC | 0.14 | 0.009 |
| mRNA | JQ-1 | GDSC1000 | pan-cancer | AAC | 0.088 | 0.009 |
| mRNA | etoposide | GDSC1000 | pan-cancer | AAC | -0.092 | 0.01 |
| mRNA | GSK525762A | CTRPv2 | pan-cancer | AAC | 0.076 | 0.01 |
| mRNA | GSK269962A | GDSC1000 | pan-cancer | AAC | -0.08 | 0.02 |